Maxwell Biosciences Overview
- Founded
- 2016

- Status
- Private
- Employees
- 9

- Latest Deal Type
- Seed
- Latest Deal Amount
- $3.7M

- Investors
- 21
Maxwell Biosciences General Information
Description
Developer of a novel synthetic biomimic drug class intended to target human virus. The company's virucidal drugs mimic natural antimicrobial peptides and destroy a broad range of viruses directly, irreversibly and permanently inactivating the virus itself. Maxwell drug candidates have direct virucidal action against SARS-CoV-2, the COVID-19 virus. Maxwell's drugs have undergone testing and is effective against Herpes Simplex Virus-1 (HSV-1), Chikungunya, Hepatitis B Virus (HBV ), and Influenza.
Contact Information
- 3809 Juniper Trace
- Suite 102
- Austin, TX 78738
- United States
Maxwell Biosciences Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Seed Round | 01-Oct-2020 | $3.7M | 00.00 | Completed | Pre-Clinical Trials | |
1. Grant | 0000 | Completed | Pre-Clinical Trials |
Maxwell Biosciences Comparisons
Industry
0000000

00000000
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialMaxwell Biosciences Competitors (2)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Moderna | Venture Capital-Backed | Luçon, France | 0 | 00000 | 000000 - 000 | 00000 |
000000000000000 00 | Corporation | Saint-Amand-Les-Eaux, France |
Maxwell Biosciences Executive Team (5)
Maxwell Biosciences Board Members (4)
Name | Representing | Role | Since |
---|---|---|---|
Annelise Barron Ph.D | Maxwell Biosciences | Co-Founder, Co-Inventor & Board Member | 000 0000 |
Joshua McClure | Maxwell Biosciences | Co-Founder, Co-Inventor, Chief Executive Officer & Board Member | 000 0000 |
Robert Neville | Self | Board Member | 000 0000 |
Stephen Pearse | Yucatan Rock Ventures | Executive Chairman | 000 0000 |
Maxwell Biosciences Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialMaxwell Biosciences Investors (21)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
3Rodeo | Venture Capital | Minority | 000 0000 | 000000 0 | |
Brazos Resources, LP | Growth/Expansion | Minority | 000 0000 | 000000 0 | |
Campa Investments | Other | Minority | 000 0000 | 000000 0 | |
Capital Factory | Venture Capital | Minority | 000 0000 | 000000 0 | |
Catanzaro Family | Other | Minority | 000 0000 | 000000 0 |